Skip to content

Investigating the effect of intraovarian administration of platelet rich plasma in patients with poor ovarian response in improving the result of assisted procedures

Investigating the effect of intraovarian administration of platelet rich plasma in patients with poor ovarian response in improving the result of assisted procedures

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200905048630N5
Enrollment
88
Registered
2023-09-22
Start date
2023-10-23
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reducedovarian reserve.. Primary ovarian failure

Interventions

Intervention 1: Intervention group: 29 infertile women with reduced ovarian reserve between 18 and 45 years of age with the administration of platelet-rich plasma alone, which is prepared and injected

Sponsors

Bandare-abbas University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Informed consent of the patient (completion of the patient consent form by the patient or the patient's companion) Patients aged 18 to 45 years. Patients who have no history of ovarian surgery or ovarian endometrioma. Normal sperm analysis • POR (age over 40 years and/or a history of poor response to high-dose stimulation with less than three oocytes and/or adverse ovarian reserve tests including AMH < 1.1 ng/nl; AFC < 7) Patients without endocrine disorders such as hyperprolactinemia, PCOS, etc. Non-smoking patients Patients who do not have cardiovascular disorders.

Exclusion criteria

Exclusion criteria: Adhesion or severe damage to the pelvis or ovaries Immunological diseases Hematological diseases Platelets less than one hundred and fifty thousand per cubic millimeter Systemic use of corticosteroids within two weeks before the procedure Taking anticoagulants

Design outcomes

Primary

MeasureTime frame
The number of retrieved oocytes. Timepoint: Two months after prp injection. Method of measurement: Count the number.;The number of MII oocyte obtained. Timepoint: Two months after prp injection. Method of measurement: Count the number.;Increase in AMH. Timepoint: The day of the prp injection, and then two months after the prp injection. Method of measurement: laboratory test.

Secondary

MeasureTime frame
IVF cycle cancellation rate. Timepoint: Two months after PRP injection. Method of measurement: Count the number.;Clinical pregnancy rate. Timepoint: 6 weeks after embryo transfer. Method of measurement: Vaginal ultrasound.;Live birth rate. Timepoint: 9 months after embryo transfer. Method of measurement: Count the number.;Ongoing pregnancy rate. Timepoint: 20 weeks after embryo transfer. Method of measurement: Ultrasound.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Maryam Azizi Kutenaee

Bandare-abbas University of Medical Sciences

maryamazizikut86@gmail.com+98 76 3333 0755

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026